Cargando…
Identification of an alpha-1 antitrypsin variant with enhanced specificity for factor XIa by phage display, bacterial expression, and combinatorial mutagenesis
Coagulation Factor XIa (FXIa) is an emerging target for antithrombotic agent development. The M358R variant of the serpin alpha-1 antitrypsin (AAT) inhibits both FXIa and other proteases. Our aim was to enhance the specificity of AAT M358R for FXIa. We randomized two AAT M358R phage display librarie...
Autores principales: | Bhakta, Varsha, Hamada, Mostafa, Nouanesengsy, Amy, Lapierre, Jessica, Perruzza, Darian L., Sheffield, William P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7946950/ https://www.ncbi.nlm.nih.gov/pubmed/33692375 http://dx.doi.org/10.1038/s41598-021-84618-7 |
Ejemplares similares
-
Stepwise Reversion of Multiply Mutated Recombinant Antitrypsin Reveals a Selective Inhibitor of Coagulation Factor XIa as Active as the M358R Variant
por: Hamada, Mostafa, et al.
Publicado: (2021) -
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss
por: Sheffield, William P., et al.
Publicado: (2018) -
Selection and characterization of a DNA aptamer inhibiting coagulation factor XIa
por: Donkor, David A., et al.
Publicado: (2017) -
Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
por: Scott, Benjamin M., et al.
Publicado: (2014) -
Correction: Phage Display of the Serpin Alpha-1 Proteinase Inhibitor Randomized at Consecutive Residues in the Reactive Centre Loop and Biopanned with or without Thrombin
por: Scott, Benjamin M., et al.
Publicado: (2020)